Aragen is a trusted R&D and manufacturing partner that transforms your ideas into solutions, keeping you ahead in the race for better health. We have more than 20 years of experience providing a range of contract research, development and manufacturing services across the drug development... Read More
Fralock (ISO 13485) provides design, development, and manufacturing services for the medical, diagnostic, and life science industries utilizing precision technologies (laser, rotary die-cut, lamination, CNC machining). Whether it is prototype or production volumes, the company offers solutions... Read More
NOF America Corporation focuses on Drug Delivery Products (DDS Development Div.), Specialty Chemicals (Oleo & Specialty Chemicals Div.), Life Science Products (Life Science Products Div.) and Speciality Polymers in North America. Read More
Aphena’s facilities are DEA licensed to handle class II-V controlled substances. All controlled substances are secured, handled and stored in accordance with DEA regulations Read more »
Aphena offers bottling solutions for solid-dose products: tablets, capsules, caplets, soft gels and gel caps. Our turnkey services include purchasing all of the components, including a broad selection of bottle sizes and resins, cotton or rayon fillers and desiccants, outserts/inserts, CRC or... Read more »
Aphena offers an array of blister packaging in thermoform and cold-form blisters. Aphena’s new PharmaWorks machines offer state of the art quality system to provide a fast and cost-effective turnaround of each production batch. The automated blister equipment allows for short or long-run... Read more »
By Aphena Pharma Solutions
A November 2016 study from Industry Standard Research Reports reveals that life sciences companies now outsource two-thirds of their manufacturing activities to CMOs. For small and mid-sized companies - where outsourcing manufacturing isn't just a convenience, it's a
necessity - that figure is...
Read More
By Aphena Pharma Solutions
With tightening regulations and rising costs, the pharmaceutical industry is being presented with a consistent challenge in the marketplace: Do more with less. As a result, pharma companies are reducing their internal capacities in manufacturing and R&D and are, instead, increasing their...
Read More
Posted 1/13/2022
Posted 1/13/2022